The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy

BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used agents that can cause serious gastrointestinal (GI) side effects. For patients at increased risk of NSAID-related GI complications, prophylaxis with either a nonselective NSAID plus gastroprotective agent (GPA) or, alternative...

Full description

Bibliographic Details
Main Authors: Bogdan Superceanu, Sander Veldhuyzen van Zanten, Chris Skedgel, Michael Shepherd, Ingrid Sketris
Format: Article
Language:English
Published: Hindawi Limited 2010-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2010/397610
id doaj-5b96bc4677824736adcf355230dab53d
record_format Article
spelling doaj-5b96bc4677824736adcf355230dab53d2020-11-24T23:45:21ZengHindawi LimitedCanadian Journal of Gastroenterology0835-79002010-01-0124848148810.1155/2010/397610The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug TherapyBogdan Superceanu0Sander Veldhuyzen van Zanten1Chris Skedgel2Michael Shepherd3Ingrid Sketris4Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaFaculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, CanadaCollege of Pharmacy, Dalhousie University, Halifax, Nova Scotia, CanadaBACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used agents that can cause serious gastrointestinal (GI) side effects. For patients at increased risk of NSAID-related GI complications, prophylaxis with either a nonselective NSAID plus gastroprotective agent (GPA) or, alternatively, therapy with a cyclooxygenase-2 selective inhibitor with or without a GPA such as a proton pump inhibitor (PPI), is recommended.http://dx.doi.org/10.1155/2010/397610
collection DOAJ
language English
format Article
sources DOAJ
author Bogdan Superceanu
Sander Veldhuyzen van Zanten
Chris Skedgel
Michael Shepherd
Ingrid Sketris
spellingShingle Bogdan Superceanu
Sander Veldhuyzen van Zanten
Chris Skedgel
Michael Shepherd
Ingrid Sketris
The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy
Canadian Journal of Gastroenterology
author_facet Bogdan Superceanu
Sander Veldhuyzen van Zanten
Chris Skedgel
Michael Shepherd
Ingrid Sketris
author_sort Bogdan Superceanu
title The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy
title_short The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy
title_full The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy
title_fullStr The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy
title_full_unstemmed The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy
title_sort rate of prescribing gastrointestinal prophylaxis with either a proton pump inhibitor or an h2-receptor antagonist in nova scotia seniors starting nonsteroidal anti-inflammatory drug therapy
publisher Hindawi Limited
series Canadian Journal of Gastroenterology
issn 0835-7900
publishDate 2010-01-01
description BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used agents that can cause serious gastrointestinal (GI) side effects. For patients at increased risk of NSAID-related GI complications, prophylaxis with either a nonselective NSAID plus gastroprotective agent (GPA) or, alternatively, therapy with a cyclooxygenase-2 selective inhibitor with or without a GPA such as a proton pump inhibitor (PPI), is recommended.
url http://dx.doi.org/10.1155/2010/397610
work_keys_str_mv AT bogdansuperceanu therateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy
AT sanderveldhuyzenvanzanten therateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy
AT chrisskedgel therateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy
AT michaelshepherd therateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy
AT ingridsketris therateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy
AT bogdansuperceanu rateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy
AT sanderveldhuyzenvanzanten rateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy
AT chrisskedgel rateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy
AT michaelshepherd rateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy
AT ingridsketris rateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy
_version_ 1725496184242438144